An observational, multicentre study of cabazitaxel in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel (CAPRISTANA)

OBJECTIVES: To obtain routine clinical practice data on cabazitaxel usage patterns for patients with metastatic castration‐resistant prostate cancer (mCRPC) and to describe physician‐assessed cabazitaxel effectiveness, health‐related quality of life (HRQoL) and safety. PATIENTS AND METHODS: CAPRISTA...

Descripción completa

Detalles Bibliográficos
Autores principales: Carles, Joan, Pichler, Angelika, Korunkova, Hana, Tomova, Antoaneta, Ghosn, Marwan, El Karak, Fadi, Makdessi, Joseph, Koroleva, Irina, Barnes, Gisoo, Bury, Denise, Özatilgan, Ayse, Hitier, Simon, Katolicka, Jana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Urological Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379594/
https://www.ncbi.nlm.nih.gov/pubmed/30098093
http://dx.doi.org/10.1111/bju.14509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379594/
https://www.ncbi.nlm.nih.gov/pubmed/30098093
http://dx.doi.org/10.1111/bju.14509

Ejemplares similares